I take back what i said earlier - it would seem we have a buyer working orders in the background .. far to many roundnumber trades /delayed.. plus we did a a few earlier in the week
AIM is a very odd place - Why on hells earth would you pay nearly 32p today if you wasnt willing to by at 27p 2 day ago - I t does go to show how much hot money goes in and out of AIM shares - Not complianing - I feel much better floating above 30p. just bemused
Morning - Its all about Cirt for me.. The company has stated that they dont add yet to be paid tests as recievables and they bulk invoice ffor insurance claims therefore I dont expect 2023 numbers to be huge. Can pretty much works it out on a mid case of say about june being the last month to make it into the accounts.. FY 2023 Rev will be about £700k Ish IMO, but that not the important thing as june alone would be £250k.. its the current grow from June that im looking for.
Nice little find Dug
Trades have woken up today - over 550k volume so far
Its been an odd few weeks for OBD voulme and share price. OBD presented for Jeffries Investments 15th -16th November and the SP rallied on a flurry of buys, over the nevt few weeks volume rose and it seem to push down relentlessly..Now volume has dissapeared and floating around this level for a few sessions now..
Having witnessed many a AIM co'sBIO raise funds in the past, the recent movements suggest to me that OBD may well have got a placing away around the 28-30p level.. Obviously cant tell, but just seen these types of movements before (espsially after prsenting at Institutional Investment seminars) , I hope they have as it would remove the one nagging doubt and shore up the SP more than any dilution. Just an enquiring thought
UK Lab cannot be far from certification, I think the company stated uk lab early 2024 , so prepping for the now
5085
Thanks - I have no doubt in that at all that BUPA will be using PSE at some point in the near future. Given the relationship we have with Cirt, PSE must have been on the Agenda within those Cirt discusions and as well have seen BUPA is proud to pioneer with new technology. Just a matter of time IMO
Im not one for trade watching but noticed the volume drop right off over the last two sessions , gut feeling that this will bounce over the next few sessions..However i'm never right, so not worth posting really - Just bored :)
Hi Dug
Its still very early days for PSE.. I think it will take a while to get agreements in place, may start to get news on those over the coming months, thats why steve is onboard..Cant see there being rocket sales of PSE just yet, but all looking good
Agree - but most important thimg right now is to get sales up and stop burning through money.. I'm sure they are fully aware of these trial in significantly more detail than yourself... Teaching to suck eggs a bit , without any knowledge of the commcial and resourse constraints that go with these.. I sure they dont need to be told
Listen to the presentation Dug .. they are already publisihng technical case data from the US CIRT. Its a clearly spelt out strategy and the guy knows his stuff..other may need convincing, but that the way they are going
Cyber - I dont think there is a single oncologist that would do a Cirt and then refuse treatment.. As it stands the current methods cant predict, cyrstal ball and luck of the gods, this is about making informed rational.. At last count accumilative 400 tests, and case studes starting to build waht will be a very big pool of data,..Same with PSE - Itswill go straight into Private Hospitals and when you have enough data that case file will be taken to NICE etc ..Rather than wait cap in hand for 3 years .. BUPA deal is a clear example ... These are not my words . In May's presentation its spelt out very clearly in the Q+A
Real World Data will be trickling through for CiRT, OBD already starting to referece case studies from Cirt - There no better validation than in the Clinic .
Another thing - Steve Arrivo has arrived .. impressive CV and not your usual AIM SVP - couldn't have found a Better Scalp.
NU - Agree, the fact that a company delivered ahead of schedule is a big positive - it literally never happens on the AIM - and getting the Medi Code in 3 months !!!! Come on .. Mega impressive .. other UK bios with diagnostic devices with FDA still waiting nearly pushing 2 years with no joy
Spot on - it's the reason I'm invested, would love an update on CiRT, but me thinks we may have to wait until after Xmas... I really don't think the management are getting credit for what they've achieved in such a short timeline
Well - Dug .. you can now buy back if you wish at profit (wish I sold some of my golden tickets now :0)
Chill -Nothing posted on these boards affect your investment, only your faith in humanity!!!
Uk is obviously a market that OBD would like to have , and the BUPA Deal is by far the biggest OBD have achieved so far .. but it has been stated many many times in presentations etc that they are looking to penetrate the US Market , they are mostly based in the US and me VP on sales is based in the US .. UK IS Small fry .. Whilst the addressable market is only 5 times bigger , the Private Medical sector is 100's of time bigger dwarfing the NHS at least tenfold .. BUPA seal covers over 2 million people for CIrt and that can be done with one signature .. same can be done in the US .. forget NHS it's not worth the effort -(as many a CEO will tell you)
I fully agree - not sure why PSE NHS taking up so much keystrokes ! TBH it's not even up for debate - OBD have made thier strategy very clear in the presentations ..